Showing results (151-160 of 157) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
Molecular Cancer Therapeutics|August 24, 2016
The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate CancerMichael Mattie, Arthur Raitano, Kendall Morrison, et al.Infection Control and Hospital Epidemiology|January 28, 2021
Novel method of calculating adjusted antibiotic use by microbiological burdenHana R Winders, Majdi N Al-Hasan, Bruce M Jones, et al.Molecular Cancer Therapeutics|May 3, 2015
AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AMLDaniel S Pereira, Claudia I Guevara, Liqing Jin, et al.Antibiotics (Basel, Switzerland)|May 20, 2020
Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to Enterobacter, Serratia, and Citrobacter SpeciesCaroline Derrick, P Brandon Bookstaver, Zhiqiang K Lu, et al.Cancer Research|March 26, 2016
Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer ModelsPia M Challita-Eid, Daulet Satpayev, Peng Yang, et al.Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
De novo MAP2K4 variants cause a novel neurodevelopmental syndrome with impaired JNK signaling in iPSC-derived neuronsTomoki T Nomakuchi, Alyssa L Rippert, Sabrina A Santos De León, et al.Open Forum Infectious Diseases|March 4, 2024
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022Reagan K Barfield, Matthew L Brown, Benjamin Albrecht, et al.Pageof 16